Search Results - Ian Chau
- Showing 1 - 20 results of 104
- Go to Next Page
-
1
Treatment in advanced colorectal cancer: what, when and how? by Ian Chau, David Cunningham
Published 2009Revisão -
2
Updates on Systemic Therapy for Hepatocellular Carcinoma by Panagiotis Ntellas, Ian Chau
Published 2024Artigo -
3
-
4
Molecular target: pan-AKT in gastric cancer by Byung Woog Kang, Ian Chau
Published 2020Revisão -
5
Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer by Milind Javle, Elizabeth Smyth, Ian Chau
Published 2014Revisão -
6
-
7
-
8
-
9
Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Indiv... by Ian Chau, Andy Norman, David Cunningham, Justin S. Waters, Jacqui Oates, Paul J. Ross
Published 2004Artigo -
10
Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 tria... by Alicia Okines, Olivia del Puerto, David Cunningham, Ian Chau, Eric Van Cutsem, Leonard B. Saltz, J Cassidy
Published 2009Artigo -
11
Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey by Sing Yu Moorcraft, Cheryl Marriott, Clare Peckitt, David Cunningham, Ian Chau, Naureen Starling, David Watkins, Sheela Rao
Published 2016Artigo -
12
-
13
Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/... by Alicia Okines, S. Ashley, David Cunningham, J. Oates, Andrea Turner, Janine Webb, Claire Saffery, Yu Jo Chua, Ian Chau
Published 2010Artigo -
14
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial by Thomas Gruenberger, John Bridgewater, Ian Chau, Pilar Alfonso, Michel Rivoire, Satvinder Mudan, S. Lasserre, Matthias Hermann, Daniel Waterkamp, René Adam
Published 2014Artigo -
15
Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience by Hendrik‐Tobias Arkenau, Geoff Chong, David Cunningham, David Watkins, Bhawna Sirohi, Ian Chau, Andrew Wotherspoon, A. Norman, Alan Horwich, Estella Matutes
Published 2007Carta -
16
The impact of primary tumour origins in patients with advanced oesophageal, oesophago–gastric junction and gastric adenocarcinoma—individual patient data from 1775 patients in four... by Ian Chau, A. Norman, David Cunningham, J. Oates, Robert D. Hawkins, Timothy Iveson, M. Nicolson, Peter Harper, Michel Seymour, Tamas Hickish
Published 2009Revisão -
17
Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic can... by J.C. Bendell, Eileen M. O’Reilly, Mark R. Middleton, Ian Chau, Howard S. Höchster, Anitra Fielding, Wendy Burke, Howard A. Burris
Published 2015Artigo -
18
Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience by Khurum Khan, Clare Peckitt, Francesco Sclafani, David Watkins, Sheela Rao, Naureen Starling, Vikram Jain, Sachin Trivedi, Susannah Stanway, David Cunningham, Ian Chau
Published 2015Artigo -
19
MRI-Diagnosed Tumor Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal Cancer by Amy Lord, Nigel D’Souza, Annabel Shaw, Zena Rokan, Brendan Moran, Muti Abulafi, Shahnawaz Rasheed, Anuradha Chandramohan, Alison Corr, Ian Chau, Gina Brown
Published 2020Artigo -
20
Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer by Ian Chau, Gina Brown, David Cunningham, Diana Tait, Andrew Wotherspoon, A. Norman, Niall C. Tebbutt, Mark Hill, Paul J. Ross, Alison Massey, J. Oates
Published 2006Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer
Oncology
Colorectal cancer
Chemotherapy
Gastroenterology
Biology
Surgery
Immunotherapy
Pathology
Gene
Randomized controlled trial
Confidence interval
Clinical trial
Clinical endpoint
Oxaliplatin
Adverse effect
Breast cancer
Cetuximab
Genetics
Biochemistry
Hazard ratio
Ramucirumab
Alternative medicine
Immunology
Capecitabine
KRAS
Phases of clinical research
Placebo